221 related articles for article (PubMed ID: 22076177)
21. Critical Role of CD6highCD4+ T Cells in Driving Th1/Th17 Cell Immune Responses and Mucosal Inflammation in IBD.
Ma C; Wu W; Lin R; Ge Y; Zhang C; Sun S; Cong Y; Li X; Liu Z
J Crohns Colitis; 2019 Mar; 13(4):510-524. PubMed ID: 30395204
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab.
Hernández P; Moreno E; Aira LE; Rodríguez PC
Curr Drug Targets; 2016; 17(6):666-77. PubMed ID: 26844560
[TBL] [Abstract][Full Text] [Related]
23. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor.
Ibáñez A; Sarrias MR; Farnós M; Gimferrer I; Serra-Pagès C; Vives J; Lozano F
J Immunol; 2006 Jul; 177(2):1152-9. PubMed ID: 16818773
[TBL] [Abstract][Full Text] [Related]
24. Relevance of CD6-mediated interactions in T cell activation and proliferation.
Gimferrer I; Calvo M; Mittelbrunn M; Farnós M; Sarrias MR; Enrich C; Vives J; Sánchez-Madrid F; Lozano F
J Immunol; 2004 Aug; 173(4):2262-70. PubMed ID: 15294938
[TBL] [Abstract][Full Text] [Related]
25. Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis.
Consuegra-Fernández M; Julià M; Martínez-Florensa M; Aranda F; Català C; Armiger-Borràs N; Arias MT; Santiago F; Guilabert A; Esteve A; Muñoz C; Ferrándiz C; Carrascosa JM; Pedrosa E; Romaní J; Alsina M; Mascaró-Galy JM; Lozano F
Cell Mol Immunol; 2018 Oct; 15(10):898-906. PubMed ID: 29225340
[TBL] [Abstract][Full Text] [Related]
26. Recognition of diverse proteins by members of the immunoglobulin superfamily: delineation of the receptor binding site in the human CD6 ligand ALCAM.
Skonier JE; Bowen MA; Emswiler J; Aruffo A; Bajorath J
Biochemistry; 1996 Sep; 35(38):12287-91. PubMed ID: 8823162
[TBL] [Abstract][Full Text] [Related]
27. CD6 as a potential target for treating multiple sclerosis.
Li Y; Singer NG; Whitbred J; Bowen MA; Fox DA; Lin F
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2687-2692. PubMed ID: 28209777
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of Murine Collagen-Induced Arthritis by Targeting CD6.
Li Y; Ruth JH; Rasmussen SM; Athukorala KS; Weber DP; Amin MA; Campbell PL; Singer NG; Fox DA; Lin F
Arthritis Rheumatol; 2020 Sep; 72(9):1505-1513. PubMed ID: 32307907
[TBL] [Abstract][Full Text] [Related]
29. Modulation of CD6 function through interaction with Galectin-1 and -3.
Escoda-Ferran C; Carrasco E; Caballero-Baños M; Miró-Julià C; Martínez-Florensa M; Consuegra-Fernández M; Martínez VG; Liu FT; Lozano F
FEBS Lett; 2014 Aug; 588(17):2805-13. PubMed ID: 24945728
[TBL] [Abstract][Full Text] [Related]
30. CD166 expression, characterization, and localization in salivary epithelium: implications for function during sialoadenitis.
Abidi SM; Saifullah MK; Zafiropulos MD; Kaput C; Bowen MA; Cotton C; Singer NG
J Clin Immunol; 2006 Jan; 26(1):12-21. PubMed ID: 16418799
[TBL] [Abstract][Full Text] [Related]
31. Multifaceted effects of soluble human CD6 in experimental cancer models.
Simões IT; Aranda F; Casadó-Llombart S; Velasco-de Andrés M; Català C; Álvarez P; Consuegra-Fernández M; Orta-Mascaró M; Merino R; Merino J; Alberola-Ila J; González-Aseguinolaza G; Carreras E; Martínez V; Lozano F
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217757
[TBL] [Abstract][Full Text] [Related]
32. 'Fetal-type' B and T lymphocytes in rheumatoid arthritis and primary Sjögren's syndrome.
Plater-Zyberk C; Brennan FM; Feldmann M; Maini RN
J Autoimmun; 1989 Jun; 2 Suppl():233-41. PubMed ID: 2476142
[TBL] [Abstract][Full Text] [Related]
33. The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation.
Kofler DM; Severson CA; Mousissian N; De Jager PL; Hafler DA
J Immunol; 2011 Sep; 187(6):3286-91. PubMed ID: 21849685
[TBL] [Abstract][Full Text] [Related]
34. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells.
Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH
Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923
[TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of the CD6 binding site in activated leukocyte cell adhesion molecule.
Skonier JE; Bowen MA; Emswiler J; Aruffo A; Bajorath J
Biochemistry; 1996 Nov; 35(47):14743-8. PubMed ID: 8942635
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells.
Patel DD; Wee SF; Whichard LP; Bowen MA; Pesando JM; Aruffo A; Haynes BF
J Exp Med; 1995 Apr; 181(4):1563-8. PubMed ID: 7535342
[TBL] [Abstract][Full Text] [Related]
37. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.
Whitney GS; Starling GC; Bowen MA; Modrell B; Siadak AW; Aruffo A
J Biol Chem; 1995 Aug; 270(31):18187-90. PubMed ID: 7543097
[TBL] [Abstract][Full Text] [Related]
38. CD6, a Rheostat-Type Signalosome That Tunes T Cell Activation.
Gonçalves CM; Henriques SN; Santos RF; Carmo AM
Front Immunol; 2018; 9():2994. PubMed ID: 30619347
[TBL] [Abstract][Full Text] [Related]
39. CD6 as a therapeutic target in autoimmune diseases: successes and challenges.
Pinto M; Carmo AM
BioDrugs; 2013 Jun; 27(3):191-202. PubMed ID: 23568178
[TBL] [Abstract][Full Text] [Related]
40. Biophysical Characterization of CD6-TCR/CD3 Interplay in T Cells.
Meddens MBM; Mennens SFB; Celikkol FB; Te Riet J; Kanger JS; Joosten B; Witsenburg JJ; Brock R; Figdor CG; Cambi A
Front Immunol; 2018; 9():2333. PubMed ID: 30356797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
